老年急性心肌梗死的再灌注治疗

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction;A report of the American College of Cardiology/American Heart Associa-tion Task Force on Practice Guidelines. Antman EM,Anbe DT,Armstrong PW,et al. Journal of the American College of Cardiology . 2004

Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial in-farction Final results of the randomized national multicentre trial--PRAGUE-2. Widimsky P,,Budesinsky T,,Vorac D,et al. European Heart Journal . 2003

Lack of benefit for intravenous thrombolysis in patients with myo-cardial infarction who are older than75years. Thiemann DR,,Coresh J,,Schulman SP,,Gerstenblith G,,Oetgen WJ,,Powe NR. Circulation . 2000

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative re-view of23randomised trials. Keeley EC,,Boura JA,,Grines CL. The Lancet . 2003

Indications for fibrinolytic therapy in suspected acute myocardial infarction:collabo-rative overview of early mortality and major morbidity results from all randomized trials of more than1,000patients. Fibrinolytic Therapy Trialists’(FTT)Collaborative Group. The Lancet . 1994

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. Hochman JS,,Sleeper LA,,Webb JG,et al. The Journal of The American Medical Association . 2006

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoproteinⅡb/Ⅲa inhibition. The GUSTO V Investigators. The Lancet . 2001

Efficacy and safety of tenecteplase in combina-tion with enoxaparin,abciximab,or unfractionated heparin:the AS-SENT-3randomized trial in acute myocardial infarction. ASSENT-3Investigators. The Lancet . 2001

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-seg-ment elevation. Sabatine MS,,Cannon CP,,Gibson CM,et al. The New England Journal of Medicine . 2005

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction;A report of the American College of Cardiology/American Heart Associa-tion Task Force on Practice Guidelines. Antman EM,Anbe DT,Armstrong PW,et al. Journal of the American College of Cardiology . 2004

Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial in-farction Final results of the randomized national multicentre trial--PRAGUE-2. Widimsky P,,Budesinsky T,,Vorac D,et al. European Heart Journal . 2003

Lack of benefit for intravenous thrombolysis in patients with myo-cardial infarction who are older than75years. Thiemann DR,,Coresh J,,Schulman SP,,Gerstenblith G,,Oetgen WJ,,Powe NR. Circulation . 2000

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative re-view of23randomised trials. Keeley EC,,Boura JA,,Grines CL. The Lancet . 2003

Indications for fibrinolytic therapy in suspected acute myocardial infarction:collabo-rative overview of early mortality and major morbidity results from all randomized trials of more than1,000patients. Fibrinolytic Therapy Trialists’(FTT)Collaborative Group. The Lancet . 1994

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. Hochman JS,,Sleeper LA,,Webb JG,et al. The Journal of The American Medical Association . 2006

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoproteinⅡb/Ⅲa inhibition. The GUSTO V Investigators. The Lancet . 2001

Efficacy and safety of tenecteplase in combina-tion with enoxaparin,abciximab,or unfractionated heparin:the AS-SENT-3randomized trial in acute myocardial infarction. ASSENT-3Investigators. The Lancet . 2001

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-seg-ment elevation. Sabatine MS,,Cannon CP,,Gibson CM,et al. The New England Journal of Medicine . 2005